| RS1559920341 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS1559921677 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559921797 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559921800 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559921849 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559921874 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559921944 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559921973 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922013 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922026 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922033 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922136 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922257 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922261 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922308 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922381 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922416 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS1559922462 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922470 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922472 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922473 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922476 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922498 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922528 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922558 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922577 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922621 |
FOXL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922628 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922634 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922647 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1559922657 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922782 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559922829 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1559926604 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS1559927542 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1559930732 |
QRICH1
|
Health Risk |
Pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS1559931177 |
QRICH1
|
Health Risk |
Pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS1559931820 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS1559934279 |
AGTR1
|
Health Risk |
Likely pathogenic |
Essential hypertension, Renal tubular dysgenesis |
| RS1559935542 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS1559940237 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS1559940778 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1559941008 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS1559941903 |
PDCD10
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS1559941951 |
PDCD10
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation |
| RS1559943990 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1559944592 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS1559944602 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS1559945126 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS1559945136 |
PDCD10
|
Health Risk |
Pathogenic |
— |
| RS1559952217 |
PDCD10
|
Health Risk |
Pathogenic |
— |
| RS1559952220 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS1559952317 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS1559952461 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS1559952467 |
PDCD10
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS1559952676 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS1559953791 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS1559955362 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1559955466 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1559956508 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1559956616 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS1559956683 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1559958757 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1559958979 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1559959294 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1559959758 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1559960758 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS1559961997 |
MME
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS1559963660 |
MME
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS1559966797 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS1559967310 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS1559968657 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1559968699 |
QARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS1559968729 |
CASR
|
Health Risk |
Likely pathogenic |
— |
| RS1559969429 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1559971312 |
ARL13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 8, Joubert syndrome 8 |
| RS1559971447 |
ATP2C1
|
Health Risk |
Pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS1559974529 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559975119 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559977271 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559980771 |
RNF13
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 73 |
| RS1559980785 |
RNF13
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 73 |
| RS1559981249 |
ZBTB11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 69 |
| RS1559982055 |
ATP2C1
|
Health Risk |
Pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS1559982532 |
ZBTB11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 69 |
| RS1559982739 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome type 3, Usher syndrome type 3 |
| RS1559984993 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS1559985057 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1559985787 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1559986109 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1559986946 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1559987322 |
GATA2
|
Health Risk |
Pathogenic |
multilineage dysplasia, multilineage dysplasia |
| RS1559992784 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1559995259 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1559995920 |
GYG1
|
Health Risk |
Pathogenic |
Glycogen storage disease XV, Polyglucosan body myopathy type 2 |
| RS1559998737 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, PCCB-related disorder |
| RS1559998795 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 3, Nephronophthisis 3 |
| RS1559999373 |
ARHGAP31
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 1, Adams-Oliver syndrome 1 |
| RS1560000875 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1560002113 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, NPHP3-related Meckel-like syndrome |